Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation.
about
Molecular profiling of patient-derived breast cancer xenograftsPatient-derived tumour xenografts as models for oncology drug developmentPatient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatmentOne mouse, one patient paradigm: New avatars of personalized cancer therapyLoss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppressionCharacterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage PolarizationThe future of patient-derived tumor xenografts in cancer treatment.Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalingsCurrent status and perspectives of patient-derived xenograft models in cancer research.Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapyHuman breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds.Patient-derived xenografts of non small cell lung cancer: resurgence of an old model for investigation of modern concepts of tailored therapy and cancer stem cells.Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancerNew cast for a new era: preclinical cancer drug development revisited.Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors.Patient-derived xenografts recapitulate molecular features of human uveal melanomas.Animal models for breast cancer metastasis to bone: opportunities and limitations.High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.Bypass of cell cycle arrest induced by transient DNMT1 post-transcriptional silencing triggers aneuploidy in human cells.
P2860
Q21195204-1026C65E-9B6B-44AF-B6B2-899D049E643DQ24604068-A8646E01-95AA-4381-84F6-FA5AF319E4CDQ26829125-D4B9FD35-2EE8-4347-85B8-0C7DF4EC70A8Q27023342-5405CF79-6A5E-4E70-97C6-BD07A1DAC8CFQ28512158-12D826A6-B6EC-4BED-8E51-778AC9650B22Q28552410-CD188078-9786-4244-8777-639174987B19Q33361578-20F0062E-1B2E-455D-8A05-8D7EC94ED4E4Q33557623-9FD01B44-53AE-46F6-B60E-37C41349942BQ33667686-2E5F92A6-D105-48F4-B1BB-C6149866215FQ34700019-718732E6-F57E-4318-A370-12E7EB07C581Q34897367-7C847371-628F-44B7-8C7B-CED669043477Q35884941-406D917A-6E6A-4AB4-BDEE-3CDBE5E4E68AQ36750699-3D9B8B5D-8CF2-45CD-83FC-5AE62E539AA0Q37123902-226E7061-68EB-4B3F-9DEA-99E0DB2B60A8Q37416460-AA3530B5-D071-49C2-BDF5-A5500363BF5CQ38317188-6D71C0B6-7415-4E54-BD73-4E55E3237923Q38573510-7FC6B0C9-5091-4694-B41C-CC7ACD0931CEQ38826826-72FE8E3F-17A8-4C1D-9541-DBB2A5C4B7A3Q41911545-7F2C4B7B-F4F1-4ABD-B666-12656A5B7665
P2860
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Establishment and characterisa ...... ing a germline BRCA2 mutation.
@en
Establishment and characterisa ...... ing a germline BRCA2 mutation.
@nl
type
label
Establishment and characterisa ...... ing a germline BRCA2 mutation.
@en
Establishment and characterisa ...... ing a germline BRCA2 mutation.
@nl
prefLabel
Establishment and characterisa ...... ing a germline BRCA2 mutation.
@en
Establishment and characterisa ...... ing a germline BRCA2 mutation.
@nl
P2093
P2860
P50
P356
P1476
Establishment and characterisa ...... ing a germline BRCA2 mutation.
@en
P2093
B Sigal-Zafrani
D Decaudin
E Marangoni
J-J Fontaine
L de Plater
M-F Poupon
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605900
P407
P577
2010-09-28T00:00:00Z
P5875
P6179
1052651586